Serum pro-BDNF/BDNF as a treatment biomarker for response to docosahexaenoic acid in traumatized people vulnerable to developing psychological distress: A randomized controlled trial

Translational Psychiatry

Volumn 5, Issue , 2015, Pages

  Matsuoka, Y ^a,b   Nishi, D ^a,b   Tanima, Y ^b,c   Itakura, M ^b,d   Kojima, M ^b,c   Hamazaki, K ^b,e   Noguchi, H ^b   Hamazaki, T ^b,f  

^a NATIONAL HOSPITAL ORGANIZATION DISASTER MEDICAL CENTER   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^d KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

^f Toyama Jonan Onsen Daini Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; PLACEBO; BIOLOGICAL MARKER; BRAIN-DERIVED NEUROTROPHIC FACTOR PRECURSOR; PROTEIN PRECURSOR;

ACCIDENTAL INJURY; ADULT; AGED; ARTICLE; AUSTRALIAN; CONTROLLED STUDY; DEPRESSION; DISTRESS SYNDROME; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; POSTTRAUMATIC STRESS DISORDER; RANDOMIZED CONTROLLED TRIAL; ADOLESCENT; BLOOD; INJURY; MIDDLE AGED; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; STRESS DISORDERS, POST-TRAUMATIC; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEPRESSION; DOCOSAHEXAENOIC ACIDS; DOUBLE-BLIND METHOD; EICOSAPENTAENOIC ACID; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROTEIN PRECURSORS; PSYCHIATRIC STATUS RATING SCALES; STRESS DISORDERS, POST-TRAUMATIC; WOUNDS AND INJURIES; YOUNG ADULT;

EID: 84936867496     PISSN: None     EISSN: 21583188     Source Type: Journal    
DOI: 10.1038/tp.2015.89     Document Type: Article

References (34)

1. Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci 2013; 14: 7-23.
2. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry 2006; 59: 1116-1127.
3. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894-902.
4. Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM. Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res 2002; 109: 143-148.
5. Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C et al. Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 2003; 54: 70-75.
6. Molendijk ML, Spinhoven P, Polak M, Bus BA, Penninx BW, Elzinga BM. Serum BDNF concentrations as peripheral manifestations of depression: evidence from a systematic review and meta-analyses on 179 associations (N = 9484). Mol Psychiatry 2014; 19: 791-800.
7. Fernandes BS, Berk M, Turck CW, Steiner J, Goncalves CA. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: a comparative meta-analysis. Mol Psychiatry 2014; 19: 750-751.
8. Teng HK, Teng KK, Lee R, Wright S, Tevar S, Almeida RD et al. ProBDNF induces neuronal apoptosis via activation of a receptor complex of p75NTR and sortilin. J Neurosci 2005; 25: 5455-5463.
9. Woo NH, Teng HK, Siao CJ, Chiaruttini C, Pang PT, Milner TA et al. Activation of p75NTR by proBDNF facilitates hippocampal long-term depression. Nat Neurosci 2005; 8: 1069-1077.
10. Koshimizu H, Kiyosue K, Hara T, Hazama S, Suzuki S, Uegaki K et al. Multiple functions of precursor BDNF to CNS neurons: negative regulation of neurite growth, spine formation and cell survival. Mol Brain 2009; 2: 27.
11. Yang J, Harte-Hargrove LC, Siao CJ, Marinic T, Clarke R, Ma Q et al. proBDNF negatively regulates neuronal remodeling, synaptic transmission, and synaptic plasticity in hippocampus. Cell Rep 2014; 7: 796-806.
12. Venna VR, Deplanque D, Allet C, Belarbi K, Hamdane M, Bordet R. PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus. Psychoneuroendocrinology 2009; 34: 199-211.
13. Wu A, Ying Z, Gomez-Pinilla F. Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. J Neurotrauma 2004; 21: 1457-1467.
14. Wu A, Ying Z, Gomez-Pinilla F. Docosahexaenoic acid dietary supplementation enhances the effects of exercise on synaptic plasticity and cognition. Neuroscience 2008; 155: 751-759.
15. Logan AC. Neurobehavioral aspects of omega-3 fatty acids: possible mechanisms and therapeutic value in major depression. Altern Med Rev 2003; 8: 410-425.
16. Gomez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 2008; 9: 568-578.
17. Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Hamazaki T, Hashimoto K. Potential role of brain-derived neurotrophic factor in omega-3 fatty acid supplementation to prevent posttraumatic distress after accidental injury: an openlabel pilot study. Psychother Psychosom 2011; 80: 310-312.
18. Matsuoka Y, Nishi D, Hamazaki K, Yonemoto N, Matsumura K, Noguchi H et al. Docosahexaenoic acid for selective prevention of posttraumatic stress disorder among severely injured patients: a randomized, placebo-controlled trial. J Clin Psychiatry 2015; 76: e000-e000.
19. Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Matsumura K, Noguchi H et al. Tachikawa project for prevention of posttraumatic stress disorder with polyunsaturated fatty acid (TPOP): study protocol for a randomized controlled trial. BMC Psychiatry 2013; 13: 8.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
21. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS et al. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 1995; 8: 75-90.
22. Asukai N, Hirohata S, Kato H, Konishi T. Psychometric properties of the Japanese-language version of the Clinician-Administered PTSD Scale for DSM-IV (in Japanese). Jpn J Trauma Stress 2003; 1: 47-53.
23. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389.
24. Takahashi N, Tomita K, Higuchi T, Inada T. The inter-rater reliability of the Japanese version of the Montgomery-Asberg depression rating scale (MADRS) using a structured interview guide for MADRS (SIGMA). Hum Psychopharmacol 2004; 19: 187-192.
25. Brunet A, Weiss DS, Metzler TJ, Best SR, Neylan TC, Rogers C et al. The Peritraumatic Distress Inventory: a proposed measure of PTSD criterion A2. Am J Psychiatry 2001; 158: 1480-1485.
26. Nishi D, Matsuoka Y, Noguchi H, Sakuma K, Yonemoto N, Yanagita T et al. Reliability and validity of the Japanese version of the Peritraumatic Distress Inventory. Gen Hosp Psychiatry 2009; 31: 75-79.
27. Connor KM, Davidson JR. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety 2003; 18: 76-82.
28. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 1959; 37: 911-917.
29. Matsuoka Y, Nishi D, Yonemoto N, Hamazaki K, Hashimoto K, Hamazaki T. Omega-3 fatty acids for secondary prevention of posttraumatic stress disorder after accidental injury: an open-label pilot study. J Clin Psychopharmacol 2010; 30: 217-219.
30. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int J Neuropsychopharmacol 2008; 11: 1169-1180.
31. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008; 64: 527-532.
32. Matsuoka Y, Nishi D, Noguchi H, Kim Y, Hashimoto K. Longitudinal changes in serum brain-derived neurotrophic factor in accident survivors with posttraumatic stress disorder. Neuropsychobiology 2013; 68: 44-50.
33. Berger W, Mehra A, Lenoci M, Metzler TJ, Otte C, Tarasovsky G et al. Serum brain-derived neurotrophic factor predicts responses to escitalopram in chronic posttraumatic stress disorder. Prog Neuropsychopharmacol Biol Psychiatry 2010; 34: 1279-1284.
34. Ferreira CF, Bernardi JR, Bosa VL, Schuch I, Goldani MZ, Kapczinski F et al. Correlation between n-3 polyunsaturated fatty acids consumption and BDNF peripheral levels in adolescents. Lipids Health Dis 2014; 13: 44.